Balaji Speciality Chemicals IPO GMP Today ( Live Data )

The Balaji Speciality Chemicals IPO commenced on August 18, 2023, and concluded on August 22, 2023. The allotment of shares took place on August 25, 2023, and the initiation of refunds began on August 28, 2023. The shares were credited to the demat accounts of investors on August 29, 2023. Finally, the listing of Balaji Speciality Chemicals on the stock exchange occurred on August 30, 2023.

The Balaji Speciality Chemicals IPO was priced at ₹00 per share, with a lot size of 00. The total issue size was ₹00 crores, comprising a fresh issue of ₹250 crores and an offer for sale of ₹00 crores. The IPO was listed on both the NSE and BSE.

In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 75% of the shares, the NII (Non-Institutional Investors) quota was reserved for 15% of the shares, and the retail quota was reserved for 10% of the shares.

Balaji Speciality Chemicals IPO Basic Details

Balaji Speciality Chemicals IPO GMP Today:

Balaji Speciality IPO Details:

Established in 2010, Balaji Speciality Chemicals Limited is a subsidiary of Balaji Amines Limited (BAL) and is engaged in the production of methylamines, ethylamine, specialty chemical derivatives, and pharmaceutical excipients.

The company specializes in the manufacturing of unique chemicals like Ethylenediamine, Piperazine (Anhydrous), Diethylenetriamine, Amino Ethyl Ethanol Amines, and Amino Ethyl Piperazine, utilizing the Monoethanol Amine (“MEA”) process. These chemicals serve as domestic alternatives and find applications across diverse industries such as specialty chemicals, agrochemicals, and pharmaceuticals.

Situated in Solapur, Maharashtra, Balaji Speciality Chemicals operates a manufacturing facility spanning 41,920 square meters, boasting a combined annual production capacity of 30,000 metric tons as of March 31, 2022.

During Fiscal 2022, the company catered to 182 clients, including manufacturers of specialty chemicals, agrochemicals, pharmaceuticals, and distributors. Noteworthy names in its clientele encompass Nanjing Union Chemical Company Limited, Korea India Limited, UPL Limited, Dr. Reddy’s Laboratories Limited, and Aarti Drugs Limited.

The company’s financial performance showcased a revenue of ₹538.81 million in Fiscal 2020, ₹1,744.01 million in Fiscal 2021, and ₹5,142.80 million in Fiscal 2022.

Balaji Speciality Chemicals IPO More Details Click Here

Balaji Speciality Chemicals IPO FAQs